Inhibition of HIF-1α ameliorates pulmonary fibrosis by suppressing M2 macrophage polarization through PRMT1/STAT6 signals
- 28 December 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 146, 113931
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The glycolysis/HIF-1α axis defines the inflammatory role of IL-4-primed macrophagesCell Reports, 2023
- PRMT1-p53 Pathway Controls Epicardial EMT and InvasionCell Reports, 2020
- Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel DiseaseArchivum Immunologiae et Therapiae Experimentalis, 2020
- Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibitionInternational Journal of Cancer, 2019
- M2 macrophages induce EMT through the TGF‐β/Smad2 signaling pathwayCell Biology International, 2017
- Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophagesCellular Immunology, 2017
- Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese miceDiabetologia, 2013
- Transcriptional regulation by STAT6Immunologic Research, 2011
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid PThe International Journal of Biochemistry & Cell Biology, 2011
- Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transductionClinical Immunology, 2010